-+ 0.00%
-+ 0.00%
-+ 0.00%

Enliven Therapeutics Chief Medical Officer Helen Louise Collins reports sale of $234,203.1101 in common shares

PUBT·11/19/2026 22:08:30
Listen to the news
Enliven Therapeutics Chief Medical Officer Helen Louise Collins reports sale of $234,203.1101 in common shares
  • Enliven Therapeutics Chief Medical Officer Helen Louise Collins sold 5,000 common shares on November 17, 2026.
  • Sales comprised 4,939 shares at $46.8313 per share and 61 shares at $47.5954 per share.
  • Collins also exercised stock options for 5,000 common shares at $2.48 per share.
  • Following the transactions, she directly held 25,000 common shares and 96,268 stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001701247-26-000015), on November 19, 2026, and is solely responsible for the information contained therein.